MENU
+Compare
QNRX
Stock ticker: NASDAQ
AS OF
Nov 21 closing price
Price
$18.30
Change
-$0.12 (-0.65%)
Capitalization
15.52M

QNRX Quoin Pharmaceuticals Ltd Forecast, Technical & Fundamental Analysis

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases... Show more

Industry: #Biotechnology
QNRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for QNRX with price predictions
Nov 21, 2025

QNRX sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for QNRX moved above the 200-day moving average on October 28, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 13, 2025. You may want to consider a long position or call options on QNRX as a result. In of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for QNRX just turned positive on November 14, 2025. Looking at past instances where QNRX's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

QNRX moved above its 50-day moving average on November 11, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where QNRX advanced for three days, in of 215 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 78 cases where QNRX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where QNRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

QNRX broke above its upper Bollinger Band on November 14, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.720) is normal, around the industry mean (27.205). P/E Ratio (0.012) is within average values for comparable stocks, (51.591). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.881). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (328.409).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. QNRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QNRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
QNRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of biological products for cellular therapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
42127 Pleasant Forest Court
Phone
+1 703 980-4182
Employees
4
Web
https://www.quoinpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NOVT106.517.29
+7.35%
Novanta
DWTX6.380.43
+7.23%
Dogwood Therapeutics Inc
DSP9.800.39
+4.14%
Viant Technology
GLDD11.860.20
+1.72%
Great Lakes Dredge & Dock Corp
GFI38.450.50
+1.32%
Gold Fields Ltd

QNRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, QNRX has been loosely correlated with NEVPF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if QNRX jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNRX
1D Price
Change %
QNRX100%
+0.43%
NEVPF - QNRX
38%
Loosely correlated
N/A
ATNM - QNRX
35%
Loosely correlated
+3.10%
PRQR - QNRX
32%
Poorly correlated
N/A
WVE - QNRX
32%
Poorly correlated
+4.37%
PTGX - QNRX
31%
Poorly correlated
+1.43%
More